Humana reported third-quarter 2026 financial results with GAAP earnings of $1.33 per share and an adjusted loss of $0.70 per share. The company raised its full-year 2026 adjusted EPS guidance to at least $9.50 while also expanding its CenterWell and Medicaid patient footprints.
Reported third-quarter 2026 GAAP EPS of $1.33 and an adjusted loss per share of $0.70.
Raised full-year 2026 adjusted EPS guidance to at least $9.50, up from the prior expectation of at least $9.00.
CenterWell Senior Primary Care grew by 146,800 patients year-to-date, representing a 30 percent increase.
Medicaid membership grew by 103,600 members, or 7 percent, year-to-date.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Humana's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$129.66B
+10.1%
$9.84
-1.4%
0.9%
FY2024
$117.76B
+10.7%
$9.98
-50.1%
1.0%
FY2023
$106.37B
+14.5%
$20.00
-9.4%
2.3%
FY2022
$92.87B
+11.8%
$22.08
-2.6%
3.0%
FY2021
$83.06B
+7.7%
$22.67
-10.4%
3.5%
Frequently asked questions
When is Humana's next earnings date?
Humana (HUM) is scheduled to report on Friday, November 06, 2026 before the market opens. Analysts expect EPS of $-1.03.
What did Humana earn last quarter?
For the quarter ended Sep 2026, Humana reported diluted EPS of $1.33 (-17.9% year over year) on revenue of $41.16B (+26.1%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.